![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/48 | |
C07K 14/755 | |||
A61K 38/37 | |||
A61P 7/04 |
(11) | Number of the document | 2257311 |
(13) | Kind of document | T |
(96) | European patent application number | 09714286.3 |
Date of filing the European patent application | 2009-02-26 | |
(97) | Date of publication of the European application | 2010-12-08 |
(45) | Date of publication and mention of the grant of the patent | 2014-04-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/035339 |
Date | 2009-02-26 |
(87) | Number | WO 2009/108806 |
Date | 2009-09-03 |
(30) | Number | Date | Country code |
32006 | 2008-02-27 | US | |
43354 | 2008-04-08 | US | |
58869 | 2008-06-04 | US |
(72) |
DEFREES, Shawn, US
VANDAHL, Brian, Berg, Stidsen, DK
BOLT, Gert, DK
STENNICKE, Henning, Ralf, DK
THIM, Lars, DK
STEENSTRUP, Thomas, Dock, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | CONJUGATED FACTOR VIII MOLECULES |
CONJUGATED FACTOR VIII MOLECULES |